Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Expands By 40.6%

Cosmos Health Inc. (NASDAQ:COSM) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 804,000 shares, an increase of 40.6% from the February 13th total of 571,900 shares. Approximately 4.9% of the company’s shares are sold short. Based on an average daily volume of 412,700 shares, the short-interest ratio is presently 1.9 days.

Cosmos Health Stock Performance

Shares of COSM stock traded up $0.01 on Monday, reaching $0.49. The stock had a trading volume of 118,141 shares, compared to its average volume of 499,931. Cosmos Health has a 12 month low of $0.44 and a 12 month high of $1.58. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $11.47 million, a price-to-earnings ratio of -0.21 and a beta of 5.60. The firm’s 50-day moving average is $0.65 and its two-hundred day moving average is $0.75.

Insiders Place Their Bets

In other Cosmos Health news, CFO Georgios Terzis bought 85,778 shares of Cosmos Health stock in a transaction that occurred on Friday, December 20th. The stock was acquired at an average price of $0.58 per share, for a total transaction of $49,751.24. Following the completion of the acquisition, the chief financial officer now owns 727,263 shares of the company’s stock, valued at $421,812.54. This trade represents a 13.37 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Grigorios Siokas bought 132,572 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average cost of $0.49 per share, for a total transaction of $64,960.28. Following the transaction, the chief executive officer now owns 4,029,588 shares of the company’s stock, valued at $1,974,498.12. The trade was a 3.40 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 1,175,618 shares of company stock worth $701,169. Company insiders own 15.61% of the company’s stock.

Institutional Inflows and Outflows

An institutional investor recently raised its stake in Cosmos Health stock. Geode Capital Management LLC raised its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM) by 29.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the quarter. Geode Capital Management LLC owned approximately 0.83% of Cosmos Health worth $129,000 at the end of the most recent reporting period. Institutional investors own 12.61% of the company’s stock.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.